A new study suggests that low-dose aspirin may help people avoid the worst COVID-19 symptoms and side effects, USA Today reports.
- The study – conducted by researchers at George Washington University – reviewed data from 412 patients who went to the hospital from March to July 2020 for COVID-19.
- Nearly 24% of patients took aspirin seven days or less before being admitted to the hospital, or within 24 hours after being admitted, according to the study published in the journal Anesthesia and Analgesia.
- According to the study, more than 40% of the patients improved their symptoms compared to those who did not use any version of the drug.
- “Aspirin may have lung protective effects and reduce the need for mechanical ventilation, admission to treatment needs and hospital deaths in COVID-19 patients,” the report said.
But remember – the researchers said that “a randomized controlled trial would be necessary to establish a causal link”, according to USA Today.
What about aspirin for the COVID-19 vaccine?
The Centers for Disease Control and Prevention said people should talk to their doctors about using ibuprofen, paracetamol, aspirin or antihistamines if they are constantly in pain or discomfort due to the vaccine.